Novartis sees 20 per cent profit rise

Basel-based Novartis said revenues rose by 10 per cent Keystone

The Swiss pharmaceutical group, Novartis, has posted record-breaking net profits of SFr1.79 billion ($1.1 billion) for the first quarter, a 20 per cent rise on the previous year.

This content was published on April 18, 2002 - 08:28

According to a company statement, revenue also increased by 10 per cent, to SFr7.8 billon, compared to SFr7.22 for the same period last year.

swissinfo with agencies

This article was automatically imported from our old content management system. If you see any display errors, please let us know:

Share this story

Join the conversation!

With a SWI account, you have the opportunity to contribute on our website.

You can Login or register here.